The receptor mechanisms mediating the retrograde axonal transport of the neurotrophins have been investigated in adult rats. We show that transport of the TrkB ligands NT-4 and BDNF to peripheral neurons is dependent on the low affinity neurotrophin receptor (LNR). Pharmacological manipulation of LNR in vivo using either an anti-LNR antibody or a soluble recombinant LNR extracellular domain completely blocked retrograde transport of NT-4 and BDNF to sensory neurons, while having minimal effects on the transport of NGF in either sensory or sympathetic neurons. Furthermore, in mice with a null mutation of LNR, the transport of NT-4 and BDNF, but not NGF, was dramatically reduced. These observations demonstrate a selective role for LNR in retrograde transport of the various neurotrophins from distinct target regions in vivo.
Introduction
Target-derived neurotrophic factors promote the survival of specific neuronal populations and thus assist in sculpting the developing nervous system (Thoenen, 1991 ; Lindsay et al., 1994) . The neurotrophins--nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), NT-4 (also known as , and NT-6--each display a distinct spatial and temporal pattern of expression in the targets of peripheral neurons (Leibrock et al., 1989; Maisonpierre et al., 1990; Berkemeier et al., 1991 ; Hallb55k et al., 1991 ; GStz et al., 1994) . However, it is not clear how binding of neurotrophins at axon terminals, in many cases several centimeters from the cell body, can regulate the survival and phenotypic expression of these neurons. Receptor-mediated retrograde axonal transport of NGF, BDNF, and NT-3 has been demonstrated (DiStefano et al., 1992) , and translocation from the axon to the cell body provides a mechanism whereby neurotrophic factors can influence somal signal transduction . Additionally, recent evidence suggests that neurotrophins may also be synthesized within certain neuronal populations (Emfors et al., 1990; Schecterson and Bothwell, 1992) and therefore exert paracrine or autocrine effects on neuronal survival (Acheson et al., 1995) .
The retrograde axonal transport of NT-4 has yet to be characterized in adult peripheral neurons. NT-4 is widely expressed in peripheral tissues, including muscle, skin, and nerve (Funakoshi et al., 1993; IbdSez et al., 1993; Timmusk et al., 1993) . NT-4 promotes the survival of cultured embryonic sensory neurons (Davies et al., 1993a; Ib&Sez et al., 1993; Fandl et al., 1994) and rescues axotomized facial motor neurons in neonatal rats (Koliatsos et al., 1994) . NT-4 additionally preserves the cholinergic phenotype of cultured embryonic motor neurons (Wong et al., 1993) and of axotomized adult motor neurons (Friedman et al., 1995) . Here, we report the retrograde axonal transport of NT-4 in adult sensory and motor neurons and describe a novel receptor mechanism for the transport of NT-4 and BDNF.
Neurons display two pharmacologically distinct neurotrophin-binding sites . The low affinity binding site (KD --10 -9 M) is most likely accounted for by a transmembrane protein known as p75 or low affinity NGF receptor (Chao et al., 1986; Radeke et al., 1987) , herein termed low affinity neurotrophin receptor (LNR). All neurotrophins are able to bind competitively to this receptor , although association and dissociation rate constants of binding differ among the neurotrophins (Rodriguez-T6bar et al., 1990 (Rodriguez-T6bar et al., , 1992 . Neurotrophin-dependent differentiation and survival have not been demonstrated in cells expressing only LNR (Glass and Yancopoulos, 1993) , although it has recently been shown that binding of neurotrophins to LNR can activate signaling through the sphingomyelin pathway (Dobrowsky et al., 1994) . Higher affinity binding of the neurotrophins along with cell survival and phenotypic responses are conferred by the Trk family of receptor tyrosine kinases. NGF is the preferred ligand for TrkA, whereas TrkB is activated by both BDNF and NT-4. NT-3 is the preferred ligand for TrkC and a secondary ligand for TrkB, in that higher concentrations of NT-3 are required to activate TrkB (Chao, 1992; Klein et al., 1992; Glass and Yancopoulos, 1993) . Binding of neurotrophins results in homodimerization and autophosphorylation of Trk proteins and in initiation of signal transduction cascades involving the MAP kinases as well as cytosolic transcription factors .
The role of LNR in neurotrophin high affinity binding and responsiveness is currently controversial. Equilibrium binding studies suggest that coexpression of Trk proteins and LNR is required for high affinity binding (Hempstead et al., 1989 (Hempstead et al., , 1991 Battleman et al., 1993) . Cell survival assays show enhanced responses to neurotrophins in fibroblasts and sympathoadrenal progenitor cells express-ing both LNR and Trk proteins (Hantzopoulos et al., 1994; Verdi et al., 1994) , and pharmacological manipulation of LNR decreased the activation of immediate-early responses to NG F in PC12 cells (Barker and Shooter, 1994) . In contrast, Trk proteins have been shown to mediate responses in cells independently of LNR. For example, fibroblasts transfected with individual Trk proteins bind and are activated by their cognate ligands in the absence of LNR Glass and Yancopoulos, 1993) . Also, sympathetic neurons in culture appear to respond to a mutant of NGF that activates TrkA but does not bind LNR (Ib&~ez et al., 1992) , and antibodies that block NGF binding to LNR do not prevent neurite outgrowth of PC12 cells in response to NGF (Weskamp and Reichardt, 1991) . Cross-linking studies show that NGF binds TrkA homodimers, leading to autophosphorylation, while TrkA-LNR heterodimers have not been detected Jing et al., 1992) , suggesting that neurotrophins are similar to other growth factors in activating specific receptor tyrosine kinases by homodimerization (Schlessinger and UIIrich, 1992) . Thus, the Trk proteins alone appear capable of mediating transmembrane signaling. While LNR may cooperate to increase the affinity of Trk proteins for neurotrophins, the role of LNR in the context of a neuron in vivo remains unclear.
Previous studies have implicated LNR in retrograde transport of neurotrophins. The LNR-specific monoclonal antibody 192-1gG augments the retrograde transport of NGF by sympathetic neurons (Taniuchi and Johnson, 1985) and is itself transported by these neurons (Taniuchi and Johnson, 1985) as well as by sensory neurons (R. C. and P. S. D., unpublished data). Furthermore, the retrograde transport of endogenous LNR has been demonstrated in rat sciatic nerve and in central forebrain cholinergic pathways (Johnson et al., 1987) . Recently, LNR has been implicated in the retrograde signaling and survival of chicken isthmo-optic neurons in response to BDNF and NT-3 (von Bartheld et al., 1994) . In these studies, NGF enhanced the developmental death of these neurons, presumably by interfering with survival mechanisms involving LNR-dependent retrograde signaling from the target. In this paper, we have tested directly the hypothesis that LNR has a role in retrograde axonal transport of the neurotrophins. We propose that the transport of NT-4 and BDNF is particularly dependent on interactions with LNR, whereas the transport of NGF is relatively insensitive to manipulations of LNR.
Results

Retrograde Transport of NT-4 to Rat Sensory and Motor Neurons
Previous studies have shown that the neurotrophins NGF, BDNF, and NT-3 are all retrogradely transported by specific subpopulations of sensory neurons via distinct receptor-mediated mechanisms (DiStefano et al., 1992) , consistent with the known specificities of the Trk receptors (Glass and Yancopoulos, 1993 tendon. These injections contained PBS alone (0 rig) or 10-1000 ng of unlabeled neurotrophins. After 18 hr, the L4 and L5 DRG were removed and counted in a 7 counter. Results are the mean -.+ SD of combined counts per minute (CPM) in L4 and L5 DRG of 4-5 rats and are representative of at least two experiments. NGF potentiation of NT-4 transport (and inhibition at high doses) was also observed when 44 ng of ~251-NT-4 was injected. In (A), all doses of NGF were significantly different compared with PBS (p < .01 for 10 and 100 ng; p < .05 for 1000 rig). In (B), only the 10 ng dose was signficantly different from PBS (p < .01).
after injection into the sciatic nerve. Figure 1A shows that 12SI-NT-4 was retrogradely transported by sensory neurons; transport was inhibited in a dose-dependent fashion by the neurotrophins, with the rank order: NT-4 > BDNF = NT-3 >> NGF. Surprisingly, NGF inhibited transport at 1 p.g (the highest dose tested), but at low doses (10 ng and 100 ng) NGF caused a significant elevation of 1251-NT-4 retrograde transport ( Figure 1A ). In contrast, NT-4 (10-950 ng) did not significantly affect the transport of 12SI-NGF (data not shown). To determine whether the biphasic effects of NGF on transport were specific for 12SI-NT-4, we next coinjected unlabeled NGF with 1261-BDNF. The retrograde transport of ~251-BDNF was significantly elevated by 10 ng of NGF but not by 100 ng or 1 p.g of NGF ( Figure 1B ). As expected, unlabeled BDNF and NT-4 blocked 12SI-BDNF retrograde transport in a dose-dependent manner.
Since the transport of NT-4 was inhibited by all the neurotrophins at high doses, we postulated that interactions with non-TrkB receptors, such as LNR, might be involved in the transport of NT-4 and possibly BDNF. Two additional lines of indirect evidence suggested that LNR is crucial to NT-4 retrograde transport. The first arose from studies in which retrogradely accumulated ~251-NT-4 was colocalized with LNR immunostaining in the cell bodies of sensory neurons. Extensive accumulation of ~2SI-NT-4 was evident in small as well as large neurons in lumbar DRG (Figures 2A and 2C) . This labeling was blocked by coinjection of a 22-fold excess of unlabeled NT-4 ( Figure 2B ), corroborating the quantitation in Figure 1A . Immunostaining of ~251-NT-4-1abeled sections of DRG with an antibody against LNR (192-1gG) revealed the localization of silver grains over predominantly immunopositive cells. However, '251-NT-4 accumulation was observed occasionally in some cells with little or no apparent LNR irnmunoreactivity ( Figure 2C ).
Further evidence for the involvement of LNR in the transport of NT-4 came from studies in adult motor neurons, taking advantage of the fact that these cells normally do not express LNR but up-regulate its expression within 24 hr of sciatic nerve injury (Ernfors et al., 1989; Rende et al., 1 992) . Previous studies have shown that the other TrkB ligands, BDNF and NT-3, are retrogradely transported by normal adult motor neurons (DiStefano et al., 1992) . In contrast, 7 counting and emulsion autoradiography of spinal cords demonstrated that intact motor neurons do not transport '251-NT-4, although ~2~I-NT-4 accumulated in motor neurons when injected 3 days after sciatic nerve crush ( Figures 3A and 3B ). NT-4 transport was first evident at 1 day postlesion, was maximal at 3 days ( Figure 3D ), and remained elevated 7 days after injury (data not shown). The accumulation of 1251-NT-4 in injured motor neurons was blocked by a 22-fold excess of unlabeled , indicating that the lesioninduced transport of NT-4 was receptor mediated.
Direct Evidence for a Role of LNR in Neurotrophin Retrograde Transport: Pharmacological Manipulations
To test directly the hypothesis that retrograde transport of NT-4 and BDNF requires an interaction with LNR, two agents were used to disrupt the function of LNR in normal adult rats. First, a soluble recombinant extracellular domain of human LNR (designated here as sLNR; DiStefano et al., 1 991) was used to compete with cell surface LNR for neurotrophin binding, uptake, and transport. Retrograde transport of 12SI-NT-4, 1251-BDNF, and ~251-NT-3 was inhibited in a dose-dependent manner by coinjection with sLNR, whereas transport of 1251-NGF was almost completely unaffected ( Figure 4A ). The rank order inhibition of transport by sLNR was as follows: NT-4 > BDNF > NT-3 > NGF. Second, a polyclonal antiserum against the extracellular domain of rat LNR (designated anti-REX; Weskamp and Reichardt, 1991) To determine whether the effects of sLNR and anti-REX were selective for retrograde transport to spinal sensory neurons, we also tested these agents on transport of neurotrophins to other peripheral neurons. We chose to monitor transport from the anterior eye chamber to the superior cervical ganglion (SCG) and from the whisker pad to the trigeminal ganglion. These two systems were chosen for several reasons. First, transport to the SCG represents a nonsensory, NGF-responsive system (Johnson et al., 1978) . Second, trigeminal neurons represent a different class of sensory neurons that respond to NGF as well as to NT-4 (Ib&fiez et al., 1993) . Third, in both systems injections of ~251-1abeled neurotrophins are made in the target region, as opposed to axon shafts in the case of experiments examining transport to DRG after sciatic nerve injections; this controls for the possibility that our observations in DRG are due to differential distributions
"~.
• of LNR and Trk proteins along sensory axon shafts versus their terminals. As with transport to DRG, anti-REX inhibited the transport of ~251-NT-4 from the whisker pad to sensory neurons in the trigeminal ganglion but did not affect 12SI-NGF transport to these neurons ( Figures 5A and 5B) . Likewise, neither sLNR nor anti-REX had a significant effect on ~251-NGF transport from the anterior eye chamber to sympathetic neurons of the SCG ( Figure 5C ) when tested at doses that blocked transport of ~251-NT-4 to DRG; however, 2.6 t~g of sLNR caused a slight, but nonsignificant, reduction in ~251-NGF transport to SCG neurons, consistent with the limited effects of this agent on NGF transport to DRG.
Direct Evidence for a Role of LNR in Neurotrophin Retrograde Transport: LNR-Null Mice
We examined the retrograde transport of NT-4 and other neurotrophins in a mouse strain with a null mutation of the LNR gene (Lee et al., 1992) . Compared with normal mice, these have reduced numbers of sensory neurons in DRG (see below), which may contribute to reduced apparent levels of retrograde transport. Therefore, we measured the levels of retrograde transport of wheat germ agglutinin (WGA), which is retrogradely transported by many neurons following binding to cell surface glycoproteins (Trowjanowski, 1983) . We also measured the transport of leukemia inhibitory factor (LIF), which is transported by a mechanism involving receptors for the neuroactive cytokines . Retrograde transport of both I~I-WGA and 1251-LIF was reduced by approximately 50% in LNR-null mice compared with that in the wild type (Figure 6A and 6B) . This correlates well with estimates of DRG neuron counts in LNR-null mice (-50%-60% of wild type; K.-F. L. and S. Landis, unpublished data). It is important to note that, while fewer cells were labeled with 1251-WGA in the LNR-null mice, the intensity of cellular labeling was comparable to that seen in wild-type mice (data not shown). To show that the lack of LNR expression does not exert nonspecific effects on axonal transport of neurotrophins per se, we measured transport of ~251-BDNF to spinal cord motor neurons. In normal adult rats, spinal motor neurons transport 12SI-BDN F (DiStefano et al., 1992)
but do not express LNR (Ernfors et al., 1989; Rende et al., 1992) . Transport of ~2SI-BD NF to these neurons in LNRnull mice was identical to that in the wild type ( Figure 6C ). Given that sensory neuron populations are reduced in the DRG of LNR-null mice, we expected that retrograde transport of the neurotrophins to these neurons would be reduced also. Although this was observed, transport of the individual neurotrophins was not equally affected. Transport of ~z~I-NGF was reduced by 65% compared with wild type ( Figure 7A ). In contrast, transport of 1251-BDNF and ~251-NT-4 was more severely affected, showing reductions of 82% and 93%, respectively ( Figures 7B and 7C ). These quantitative data were confirmed and extended by emulsion autoradiography, which allowed a comparison of the intensity of labeling by each neurotrophin in wildtype and LNR-null neurons. As in the rat, cellular labeling of wild-type DRG neurons was readily detected for the three neurotrophins tested. Transport of ~251-NGF to DRG neurons was less robust in LNR-null mice than in wild-type mice; however, numerous intensely labeled profiles were evident ( Figures 8A and 8B ). In contrast, the intensity of labeling by ~2SI-BDNF ( Figures 8C and 8D ) and ~251-NT-4 ( Figures 8E and 8F ) was much lower in LNR-null neurons when directly compared with the wild type. Indeed, ~251-NT-4 labeling was very sparse, with only a few cells displaying silver grains above background levels. To rule out the possibility that the decreased transport of 1251-BDNF and 12SI-NT-4 was due to a lack of TrkB in DRG of LNR-null mice, we analyzed TrkB protein expression by immunoblotting. Aside from the full-length receptor, truncated forms of TrkB lacking the tyrosine kinase domain are predominantly expressed by glial cells in DRG (McMahon et al., 1994) . DRG from LNR-null mice contained immunoreactive bands of 95 and 140 kDa ( Figure 9A ), which were identified as full-length and truncated TrkB proteins by preabsorption of the anti-TrkB antibody with a recombinant TrkB protein ( Figure 9B ). Laser densitometry revealed that the full-length TrkB (140 kDa) in LNR-null mice was comparable to that observed in the background strains (BALB/c and 129 mice). We confirmed the expression of full-length TrkB in DRG sensory neurons of wildtype and LNR-null mice by performing in situ hybridization with a probe directed against the kinase domain of mouse TrkB (Klein et al., 1989) . The results clearly show that expression of mRNA for full-length TrkB in LNR-null mice is comparable to that in the wild type ( Figures 9C and 9D) .
Discussion
Our studies demonstrate a specific role of LN R in the retrograde transport of NT-4 and BDNF, but not NGF, in peripheral neurons. Despite the recent discoveries of the Trk family of receptor tyrosine kinases and the signal transduction cascades that they initiate in response to neurotrophins, little is known about the receptor mechanisms that mediate signal transduction in a neuron in vivo. The nature of tissue cultu re studies may limit their usefulness in evaluating the actions of neurotrophins, to the extent that cells are exposed over their entire surface to neurotrophic factors. This may result in direct stimulation of Trk proteins expressed on the cell body and in generation of local signal transduction cascades (as has been shown in Trktransfected fibroblasts; e.g., Glass and Yancopoulos, 1993) , thus circumventing the need for retrograde signaling. Recent experiments with cultured trigeminal and nodose sensory neurons from LNR-null mouse embryos revealed no alterations in survival responses to NT-4 or BDNF and a 2-to 4-fold reduction in the potency (but no change in efficacy) of NGF on trigeminal neurons (Davies et al., 1993b) . Also, our preliminary results suggest that survival of cultured embryonic rat DRG neurons in response to NGF or NT-4 is not affected by the presence of anti-REX (R. C. and P. S. D., unpublished data). However, neurotrophic factors are often acquired from distal regions that lie several centimeters from the cell body, and therefore, retrograde transport of factors or activated receptor complexes to the cell body may be a necessary step in signal transduction processes . We propose that LNR functions in vivo to mediate the retrograde transport of certain neurotrophins in distinct neuronal populations.
Evidence for Selective Involvement of LNR in Retrograde Transport of Neurotrophins
In the present study, we show that the retrograde transport of NT-4 and, to a lesser extent, BDNF by sensory neurons is highly dependent on a receptor mechanism involving LNR. This is supported by both direct and indirect experimental evidence. In cross-competition experiments, high doses of NGF are able to compete for the transport of 1251-NT-4 to sensory neurons. Since NGF is not a TrkB ligand , this suggests that the competition for NT-4 transport may be mediated by binding of NGF to LNR. At lower doses, NGF potentiates the transport of NT-4 and BDNF; this may also occur by a mechanism involving LNR occupancy, such as positive cooperativity. Indeed, positive cooperativity of binding to LNR has been demonstrated for BDNF (Rodriguez-T6bar et al., 1990) and NGF (Venkatakrishnan et al., 1990) . curs primarily in cells expressing LNR, as assessed by 192-1gG immunocytochemistry. With regard to motor neurons, we have shown here that NT-4 does not retrogradely accumulate in intact motor neurons, but does do so following axotomy (see Figure 3) . The induction of LNR in lesioned motor neurons (Ernfors et al., 1989; Rende et al., 1992) coincides with the retrograde transport of NT-4. Also, motor neurons of wild-type mice, but not those of LNR-null mice, were able to transport NT-4 1 day after axotomy (data not shown). Consistent with this, NT-4 maintains the cholinergic phenotype of injured motor neurons in adult rats (Friedman et al., 1995) . During embryonic and postnatal development, motor neurons also express LNR (Ernfors et al., 1989) and are capable of retrogradely transporting NT-4 (Koliatsos et al., 1994) . Cultured embryonic motor neurons are responsive to NT-4 (Wong et al., 1993) , and pharmacological administration of NT-4 rescues neonatal facial motor neurons from death after axotomy (Koliatsos et al., 1994) . Accordingly, distribution and transport of 12SI-NT-4 in CNS tissues occurs only where TrkB and LNR are colocalized (Wiegand et al., 1994, Soc. Neurosci., abstract) . It is important to consider the possibility that peripheral and central neuronal populations differ in their interactions with a given neurotrophin and in the degree to which LNR is utilized for retrograde transport. In this regard, transport of BDNF has been observed to neuronal populations in adult rats that apparently do not express LNR (DiStefano et al., 1992) , such as uninjured motor neurons and a variety of cells within the CNS (Yan and Johnson, 1989; Rende et al., 1992) . This would also explain why motor neurons in LNR-null mice show no altered transport of BDNF compared with the wild type. To assess directly a role for LNR in retrograde transport of the neurotrophins, we neutralized endogenous LNR by utilizing either function-blocking antibodies or a soluble extracellular domain of LNR. There were striking differences between the neurotrophins in response to these manipulations of LNR. Indeed, the rank order sensitivity of the neurotrophins to these agents showed that the retrograde transport of NT-4 to DRG sensory neurons was dramatically reduced, whereas that of NGF was only minimally affected. It is important to note that this differential sensitivity is not restricted to DRG sensory neurons but is observed in several other types of peripheral neurons as well. Accordingly, the transport of NT-4 to trigeminal sensory neurons was blocked by manipulations of LNR; this population of sensory neurons has been shown to respond to NT-4 in vitro (Ib~.Sez et al., 1993) . Furthermore, the transport of NGF to sympathetic and trigeminal sensory ganglia was not affected by sLNR or anti-REX.
We examined the characteristics of retrograde transport in a mouse strain with a null mutation of the LNR gene. In agreement with the pharmacological manipulations mentioned above and with LNR colocalization studies (see Figure 2) , the retrograde transport of NT-4 in LNR-null mice was greatly diminished compared with that of NGF. This is not due to a lack of TrkB protein or mRNA expression in DRG of LNR-null mice (see Figure 9 ). Full-length TrkB is restricted to neurons within DRG and is coexpressed with either TrkA or TrkC in most neurons, making it unlikely that TrkB-expressing neurons would be selectively vulnerable to developmental cell death (McMahon et al., 1994) . Consistent with our findings of relatively normal NGF transport in LNR-null mice, the NGF-dependent sympathetic neurons appear normal in these animals (Lee et al., 1992) , apart from reduced innervation of a small number of targets (Lee et al., 1994) .
Mechanisms of LNR Involvement in Retrograde Transport
The results of the present study clearly show that LNR acts differentially to mediate the retrograde transport of the neurotrophins. There are at least three potential stages in retrograde axonal transport at which LNR could act to mediate selectively this process, namely binding, uptake, and translocation. It is possible that the Trk proteins interact differentially with LNR even though no heterodimers of LNR and Trk proteins have been demonstrated (Jing et al., 1992; . LNR is itself internalized and retrogradely transported in peripheral nerve axons (Johnson et al., 1987) , and a monoclonal antibody directed against augments the transport of NGF in sympathetic neurons (Taniuchi and Johnson, 1985) , raising the possibility that LNR coul(~ enhance the uptake and coupling of certain neurotrophin-Trk complexes to the retrograde transport machinery; however, this model does not explain the observed selectivity of LNR with regard to retrograde transport of neurotrophins. In support of differential interaction of LNR with Trk proteins, cotransfection of fibroblast cell lines with LNR and TrkB results in greater cell growth than does cotransfection of cells with LNR and TrkA (Hantzopoulos et al., 1994) .
It is most likely that LNR execs differential effects on retrograde transport at the level of the binding event. Studies have documented that LNR, in combination with TrkA, results in enhanced cell surface binding of 1251-NGF (Hempstead et al., 1991; BatUeman et al., 1993; Mahadeo et al., 1994) . Thus, LNR could promote an enhanced binding affinity that would in turn facilitate uptake of neurotrophins into the nerve terminal. Radioligand binding analyses have shown that, while all the neurotrophins bind to LNR with equal affinities, there are differences in the dissociation rates. Thus, dissociation is fastest for NGF, followed by NT-3 and BDNF (Rodriguez-T~bar et al., 1990, 1992) . The dissociation rate constant for the binding of NTo4 to LNR is currently unknown. Interestingly, this rank order for dissociation rate constants parallels the rank order potency of 12Sl-labeled neurotrophin transport inhibition by anti-REX and sLNR (BDNF > NT-3 > NGF). It is possible that slower dissociation rates stabilize the BDNF-LNR complex (or NT-4-LNR complex) on the neuronal surface, resulting in enhanced uptake. In other studies, mutation of critical basic residues in a hairpin loop of NT-4 resulted in a mutant that did not bind to LNR and displayed 10-fold lower potency (but equal efficacy) on the survival of E16 rat DRG neurons (Ryd~n et al., 1995) . Similar mutations in BDNF, NT-3, or NGF resulted in reduced binding to LNR but no loss of biological activities (IbdSez et al., 1992; Ryddn et al., 1995) , supporting the notion that, among the neurotrophins, NT-4 shows the greatest dependence on LNR for functional signaling.
In addition to differences in direct binding parameters of various neurotrophins, the apparent selectivity of LNR for neurotrophin transport may lie in the ratio of Trk:LNR in a given cell. Mahadeo et al. (1994) reported that high affinity binding sites arise in neurons when LNR is in 10-fold excess over TrkA and that cells transfected solely with TrkA express only the lower affinity site. It is therefore conceivable that the TrkA:LNR ratio in DRG exceeds a critical level, obviating the need for LNR in retrograde transport of NGF via TrkA. Conversely, the ratio of TrkB: LNR may be lower and approximate a ratio that is more suitable for LNR interactions. In this situation, disturbing the level of LNR with high doses of NGF (1 p,g) or anti-REX may render TrkB incapable of proper binding and uptake of NT-4 or BDN F. Likewise, low doses of N GF (10 ng) may occupy excess LNR molecules and optimize the TrkB:LNR ratio, leading to the observed potentiation of NT-4 and BDNF transport by NG F. This potentiation may be of physiological significance when NGF is present in the same compartment as NT-4 or BDNF, such as in distal nerve or select target regions (Funakoshi et al., 1993; Ib&Sez et al., 1993; Timmusk et al., 1993) .
Experimental Procedures
Iodlnation of Neurotrophins and Other Proteins
Recombinant human NGF was obtained from R&D Systems (Minneapolis, MN). BDNF and NT-3 were provided by AmgenlRegeneren Partners, and NT-4 was produced in E. coil as previously described (Fandl et al., 1994) . LIF was the gift of Dr. James Miller (Aragon, Thousand Oaks, CA). WGA was purchased from Sigma (St. Louis, MO). The neuretrophins (10 p.g each), LIF (6 p,g), and WGA (15 p.g) were iodinated by a modification of the lactoperoxidase method (DiStefano et al., 1992) using carrier-free Na~2Sl (New England Nuclear, Boston, MA). Incorporation of 12~1 was routinely 70%-90%, and specific activities were in the range of 3000-4500 cpmlfmol for 12Sl-labeled neuretrophins, 1800-2400 cpm/fmol for ~2SI-LIF, and 50 cpm/pg for ~I-WGA. The biological activities of ~251-1abeled neurotrophins were verified by the chick DRG neurite outgrowth assay (Maisonpierre et al., 1990; Fandl et al., 1994) or by survival of Trk-transfected fibroblasts .
Animal Surgery and Quantification of Retrograde Transport
Adult male Sprague-Dawley rats weighing 150-200 g were obtained from Zivic-Miller, housed 2-3 per cage, and given food and water ad libitum on a 12:12 hr light:dark cycle. Rats were anesthetized with ketamine (50 mg/kg) plus xylazine (10 mg/kg), and the right sciatic nerve was exposed at the level of the tendon of the obturator internus muscle (designated obturator tendon). A 1 p_l solution containing 22-44 ng of 12Sl-labeled neurotrophin was injected into the sciatic nerve at the obturator tendon concomitantlywith I ILl of PBS or other reagents (neurotrophins, antibodies, or receptors; see below). In some animals, the sciatic nerve was crushed at the obturator tendon 1-7 days prior to injection. At 18 hr after injection, rats were sacrificed, and the L4 and L5 DRG were removed, placed in 40/0 paraformaldehyde/PBS, and counted for 1 min in a',f counter. The L4-L5 segment of the spinal cord was also dissected and counted.
For neurotrophin cross-competition studies, unlabeled neuretrophins (10-1000 ng) were coinjected with the l~l-labeled proteins. For antibody inhibition studies, 0.31-10.5 p.g of rabbit anti-REX (Weskamp and Reichardt, 1991) or rabbit anti-mouse IgG (Organon Tecknika Corp., West Chester, PA) was coinjected with the iodinated neuretrophins; sLNR was also coinjected with the iodinated neurotrophins at doses of 0.026-2.6 p.g.
For transport to trigeminal sensory neurons, 2 ILl injections, consisting of 0.5 p.I of l~l-labeled neurotrophin (22 ng) with 1.5 p.I of PBS, anti-REX (10.5 p.g), or 1 p.g of unlabeled neuretrophin, were made at two sites in the right whisker pad. Trigeminal ganglia were removed and counted 15-16 hr later. Retrograde transport of 12SI-NGF to sympathetic neurons in the SCG was assessed 16-18 hr after injection of 0.5 p.I of lz~I-NGF (22 ng) into the right anterior eye chamber along with 1.5 p.I of PBS, sLN R (2.6 p.g), anti-REX (10.5 p.g), or unlabeled NG F (1 p.g). LNR-null mice (Lee et al., 1992) and corresponding background strains (BALB/c or 129) were injected with 0.4 p.I of 12~l-labeled neurotrephins (18 rig), I~I-LIF (11 ng), or lzsI-WGA (27 ng) into the right sciatic nerve at the obturator tendon. Mice were sacrificed 18 hr later, and tissues were treated as described above.
Statistical analyses of the data were performed by ANOVA and Dunnett's post-hoc test.
All animal use in this study was conducted in compliance with approved institutional animal care and use protocols and according to NIH guidelines (Guide for the Care and Use of Laboratory Animals, NIH publication no. 1985) .
Emulsion Autoradiography
Fixed samples of DRG and spinal cord were processed for emulsion autoradiography as described previously (DiStefano et al., 1992) . LNR immunostaining was performed on some sections prior to dipping in emulsion. Sections were incubated overnight with 500 ng/m1192-1gG (Chandler et al., 1984) in PBS containing 10/0 bovine serum albumin and 1% normal horse serum. After washing in PBS, staining was visualized with biotinylated horse anti-mouse IgG and the ABC Elite kit (Vector, Burlingame, CA), using 3,3'-diaminobenzidine (Sigma) as the chromogen.
In Situ Hybridization
Mice were perfused transcardially with 4% paraformaldehyde in 100 mM sodium phosphate (pH 7.4). DRG were dissected and sectioned as described above and probed with =S-labeled antisense and sense strands from the mouse TrkB kinase domain. These probes were transcribed from a PCR fragment (RNA Transcription Kit, Stratagene, La Jolla, CA) corresponding to bases 2767-3057 of the mouse TrkB sequence (Klein et al., 1989) . In situ hybridization was performed as described elsewhere .
TrkB Western Blot
DRG from 3 BALB/c and 129 mice or 7 LNR-null mice were dissected and homogenized on ice in 1 ml of lysis buffer (20 mM Tris, 1% Nonidet P-40, 150 mM NaCI, 50 mM NaF, 5 mM benzamidine, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 10 p.g/ml leupeptin, 10 p.g/ml aprotinin [pH 7.6]). Expression of full-length and truncated TrkB proteins was assayed by wheat germ lectin-agarose precipitation and Western blotting as described (KnLisel et al., 1994 ) using a rabbit antiTrkB antibody ('rransduction Labs, Lexington, KY) and ECL detection (Amersham, Arlington Heights, IL). In blocking experiments, anti-TrkB antibodies were preincubated for 30 min with 12.5 I~g/ml soluble TrkB extracellular domain. This reagent was purified from insect cells infected with a TrkB extracellular domain-bacculovirus construct (provided by Terrence Ryan and Nancy Tobkes).
